Sponsor or institution
Clinical trials and research at Big Ten Cancer Research Consortium
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Big Ten Cancer Research Consortium that are recruiting, in United States. By phase: Phase 2 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining NovoTTF-200T(P) with Gemcitabine and Nab-Paclitaxel for Treating Resectable Pancreatic Cancer | Phase 2 | Columbus, Ohio | Recruiting | Nov 22, 2022 |
| Using temozolomide and atezolizumab for advanced small cell lung cancer | Phase 2 | Chicago, Illinois and 4 other locations | Recruiting | Jun 9, 2021 |
| Comparing Pembrolizumab to Observation after Surgery for Stage I Lung Cancer | Phase 2 | Tampa, Florida and 12 other locations | Recruiting | Mar 23, 2020 |
| Combining nivolumab and ruxolitinib for treating relapsed Hodgkin lymphoma | Phase 1/2 | Chicago, Illinois and 5 other locations | Recruiting | Sep 24, 2018 |
All recruiting trials (4)
-
Combining NovoTTF-200T(P) with Gemcitabine and Nab-Paclitaxel for Treating Resectable Pancreatic Cancer
This study is testing if a new treatment combining NovoTTF-200T(P) with two chemotherapy drugs can help people with resectable pancreatic cancer do better and have successful surgery.
-
Using temozolomide and atezolizumab for advanced small cell lung cancer
This study is testing if a combination of two drugs, temozolomide and atezolizumab, can help people with advanced small cell lung cancer live longer and feel better.
-
Comparing Pembrolizumab to Observation after Surgery for Stage I Lung Cancer
This study is testing if the drug Pembrolizumab can help people with stage I lung cancer stay cancer-free longer after surgery compared to just being monitored.
-
Combining nivolumab and ruxolitinib for treating relapsed Hodgkin lymphoma
This study is testing if combining two drugs, nivolumab and ruxolitinib, can safely help people with relapsed Hodgkin lymphoma feel better.
Quick answers
How many clinical trials run by Big Ten Cancer Research Consortium are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.